Patents
Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958)
01/2011
01/12/2011CN101010276B Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes
01/11/2011CA2461574C Process for preparing vanillylamine hyrochloride
01/06/2011WO2011000106A1 Improved cationic lipids and methods for the delivery of therapeutic agents
01/06/2011WO2010128313A3 Quaternary ammonium corrosion inhibitor
01/06/2011US20110002985 Abuse resistant drugs, method of use and method of making
01/05/2011CN101935284A Preparation method of 2-nitryl-5-substituent-1,4-p-phenylenediamine
01/04/2011US7863485 Additive and vehicle for inks, paints, coatings and adhesives
01/04/2011US7863475 5-[3-(2,6-Dimethylbenzyloxy)-phenyl]-pent-4-enoic acid ethyl ester; insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis, arteriosclerosis; side effects reduction; orally active
01/04/2011US7863245 Compositions for enhanced epithelial permeation of neuropeptide Y for treating obesity
01/04/2011CA2446063C Bis (perfluoroalkanesulfonyl)imides and their salts as surfactants/additives for applications having extreme environments and methods therefor
12/2010
12/30/2010US20100331234 Aminoalcohol lipidoids and uses thereof
12/29/2010EP2267104A2 Use of polynuclear phenolic compounds as dispersants
12/29/2010EP2266948A1 Salts of tramadol and diflunisal and their crystal form in the treatment of pain
12/29/2010EP1595863B1 Quaternary ammonium salts
12/29/2010CN101932552A 2-amino-2-phenylalkanol derivatives, preparation thereof and pharmaceutical compositions containing same
12/29/2010CN101932551A Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use
12/29/2010CN101928274A Peperphentonamine derivative
12/28/2010US7858660 oral administering a drug mixture of amantadine, rimantadine, and ribavirin or viramidine, and a neuraminidase inhibitor such as oseltamivir, zanamivir, or peramivir; viral disease treatment
12/23/2010WO2010145800A1 Salts of tramadol and diflunisal and their crystal form in the treatment of pain
12/23/2010WO2010144959A1 Analogues of anti-fibrotic agents
12/22/2010EP2264000A1 Ruthenium compound and method for producing optically active aminoalcohol compound
12/22/2010EP2263998A1 Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the beta2 adrenergic receptor
12/22/2010EP2262767A1 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors
12/22/2010EP1501840B1 Bridged bi-aromatic ligands, complexes, catalysts, processes for polymerizing and polymers therefrom
12/22/2010CN101921598A Liquid crystal alignment agent and liquid crystal display element
12/22/2010CN101921202A Process for producing 1-sbustituted 3, 5-diaminobenzene
12/22/2010CN101921201A Preparation method of Afromoterol chiral intermediate
12/22/2010CN101921200A Preparation method of N-benzyl-1-(4-methoxyphenyl)-2-propylamine
12/22/2010CN101921199A Method for preparing N-benzyl-1-(4-methoxyphenyl)-2-propylamine
12/22/2010CN101108791B Substituted benzyl ethylene derivant and method of preparing the same and use thereof
12/21/2010US7855230 FDA Orange book listed patent for fesoterodine fumarate; urinary incontinence; isobutyric acid 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethylphenyl ester is fesoteridine
12/16/2010US20100317048 Novel synthetic blocking reagents
12/15/2010EP2260023A1 Fluorine derivatives for organic electroluminescence devices
12/15/2010EP1530462B1 1-phenyl-2-dimethylaminomethyl cyclohexane compounds used for the therapy of depressive symptoms, pain, and incontinence
12/15/2010EP1499582B1 Method for chlorinating tertiary alcohols
12/15/2010CN101343238B Preparation method for 3-methoxy-N-methyldiphenylamine
12/14/2010US7851655 Inhibits white rust corrosion; one-step passivation; used in industrial water systems
12/14/2010US7851505 for the treatment of diseases associated with aberrant vascularization, copper metabolism disorders, neurodegenerative disorders, obesity or nuclear factor kappa beta dysregulation
12/14/2010US7851494 administering 5-[(4-(2,6-difluorobenzyloxy)phenyl)-methyl]-1H-tetrazole for the treatment of insulin resistance, diabetes, hyperlipemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
12/14/2010CA2478858C Catalysts and method for the production of amines
12/09/2010WO2010139521A1 A method for providing a secondary or tertiary amine
12/09/2010WO2010139520A1 A Method for Separating N,N-Dialkylbisaminoalkylether from Mixtures Comprising N,N-Dialkylbisaminoalkylether and at least one of N,N,N'-Trialkylbisaminoalkylether and N,N,N',N'-Tetraalkylbisaminoalkylether
12/09/2010US20100311974 Substituted pyrazinecarboxylic acid anilide derivatives or salts thereof, intermediates of the same, pesticides for agricultural and horticultural use, and usage thereof
12/09/2010US20100311790 Amide compounds and plant disease controlling method using same
12/09/2010US20100311728 Manipulation of brain CDP-diacylglycerol and uses thereof
12/08/2010EP2258682A2 Amino-substituted tricyclic derivatives and methods of use
12/08/2010EP2258360A2 Method for the treatment or prevention of lower urinary tract symptoms
12/08/2010CN1956970B Substituted pyrazinecarboxylic acid anilide derivative or salt thereof, intermediate thereof, agricultural/horticultural agent and use thereof
12/08/2010CN101012170B N-arylation method in water solution
12/02/2010US20100305158 Method for the treatment or prevention of lower urinary tract symptoms
12/02/2010CA2762133A1 Calcium-sensing receptor-active compounds
12/02/2010CA2762130A1 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
12/01/2010CN101899143A Triarylamine-containing polymers and electronic devices
12/01/2010CN101899141A Self-emulsifying water borne epoxy resin curing agent and preparation method thereof
12/01/2010CN101899003A Quinoline derivative-N-oxide ligand as well as preparation method and application thereof
12/01/2010CN101898972A Synthesis technology of bisoprolol
12/01/2010CN101898970A N-monosubstituted trans-1,2-diaminocyclohexane derivatives and preparation method thereof
12/01/2010CN101245041B Process for producing 4,4'-bis(2,4-diaminophenyloxy)diphenyl sulfone
11/2010
11/30/2010US7842729 substituted ethylene diamines such as N-Geranyl-N'-(2-adamanthyl)ethane-1,2-diamine, used for the treatment of leprosy or tuberculosis caused by mycobacterial infections
11/30/2010CA2597702C Process for producing 2-amino-1,3-propanediol derivatives
11/30/2010CA2437117C Method for isolating and purifying (1rs,2rs)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol
11/25/2010US20100298330 Haloallylamine inhibitors of ssao/vap-1 and uses therefor
11/24/2010EP2252575A1 2-amino-2-phenylalkanol derivatives, preparation thereof and pharmaceutical compositions containing same
11/24/2010EP2252572A1 Method for preparing combretastatin
11/24/2010CN1955159B Composite for blocking 5-hydroxytryptamine and norepinephrine reabsorbed, its preparation method and its use
11/24/2010CN101891636A Novel method for preparing esmolol hydrochloride optical isomer
11/24/2010CN101891635A Crystal forms of citric acid nolvadex and preparation method of crystal form A
11/23/2010CA2438870C Novel inhibitors of formation of advanced glycation endproducts (ages)
11/23/2010CA2431025C Process for the preparation of polyalkylphenoxyaminoalkanes
11/18/2010US20100292478 Process of preparing a radioactive compound containing a fluorine-18 isotope
11/17/2010CN101888989A Novel aryl potassium channel blockers and uses thereof
11/17/2010CN101885685A P-terphenyl compound and photosensitive body for electrophotography using such compound
11/17/2010CN101885652A Method for preparing aromatic secondary amine
11/16/2010US7834062 Aminoalkylphenols, methods of using and making the same
11/16/2010CA2618803C Substituted pyrazolecarboxylic acid anilide derivative or salt thereof, intermediate thereof, agent for agricultural and horticultural use, and use thereof
11/11/2010WO2010128313A2 Corrosion inhibitor
11/11/2010WO2010128270A2 Treatment fluids for reduction of water blocks, oil blocks, and/or gas condensates and associated methods
11/11/2010US20100286073 Compounds and methods for pharmaceutical use
11/11/2010CA2761006A1 Corrosion inhibitor
11/11/2010CA2760235A1 Treatment fluids for reduction of water blocks, oil blocks, and/or gas condensates and associated methods
11/10/2010EP2247571A2 Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use
11/10/2010CN101881755A Method for detecting esmolol hydrochlorid optical isomer by high efficiency liquid chromatography
11/09/2010US7829594 calcium receptor antagonists such as 3-{3,4-Difluoro-5-[(R)-2-hydroxy-3-(2-indan-2-yl-1,1-dimethyl-ethylamino)-propoxyl]-phenyl}-propionic acid, used to increase serum parathyroid hormone levels in mammals
11/09/2010CA2482569C Manufacture of phenyl ethylamine compounds, in particular venlafaxine
11/04/2010WO2010125923A1 Polymer-supported catalyst and method for producing aromatic hetero compound using the catalyst
11/03/2010EP2245000A1 Process of preparation of optically active alpha aminoacetals
11/03/2010EP1254196B1 Dendrimers
11/03/2010CN101875666A Optical pure 1,3-alkamine compound as well as preparation method and application thereof in preparing Dapoxetine and analogues thereof
11/02/2010CA2431065C Process for the preparation of phenethylamine derivatives
10/2010
10/28/2010US20100272642 Pet probe having an alkoxy group substituted by fluorine and hydroxy group
10/28/2010US20100271418 Self-dispersion pigment, production process of self-dispersion pigment, ink set and ink jet recording method
10/27/2010CN1585633B Phenethanolamine derivatives for treatment of respiratory diseases
10/26/2010US7820858 Reacting aldehyde with iminium ion via Mannich reaction to yield alpha substituted beta amino aldehyde; reducing in situ to alcohol form then oxidizing to carboxylic acid; industrial scale, easy purification; chemical intermediates
10/26/2010CA2449192C Novel nitriles useful as reversible inhibitors of cysteine proteases
10/26/2010CA2341345C Enzyme-catalyzed racemic cleavage of primary amines
10/21/2010US20100267778 Diphenyl ether compound, process for producing the same, and use
10/20/2010CN101868461A Process for the synthesis of E1 activating enzyme inhibitors
10/20/2010CN101863781A Preparation method of 1, 2-di (o-amino phenoxyl) ethane
10/19/2010US7816552 preparing N-(5-chloro-2-nitrophenyl)-N-methylamine by reacting 2,4-dichloronitrobenzene with methylamine, followed by reacting the resulting N-(5-chloro-2-nitrophenyl)-N-methylamine with 3,-5-dimethyl-4-nitro or amino or butoxycarbonylamino group substituted phenol; insulin resistance; antiinflammatory
10/19/2010US7816481 Polyether polyamine agents and mixtures thereof
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 140